Rapid on-site evaluation of axillary fine-needle aspiration cytology in breast cancer.
O'Leary, D P O'Brien, O Relihan, N McCarthy, J Ryan, M Barry, J Kelly, L M Redmond, H P
O'Leary, D P
O'Brien, O
Relihan, N
McCarthy, J
Ryan, M
Barry, J
Kelly, L M
Redmond, H P
Advisors
Editors
Other Contributors
Date
2012-06
Date Submitted
Keywords
Other Subjects
Subject Mesh
Adenocarcinoma, Mucinous
Adult
Aged
Axilla
Biopsy, Fine-Needle
Breast Neoplasms
Carcinoma, Ductal, Breast
Carcinoma, Lobular
Feasibility Studies
Female
Humans
Lymph Nodes
Lymphatic Metastasis
Middle Aged
Neoplasm Staging
Point-of-Care Systems
Prenatal Care
Sensitivity and Specificity
Sentinel Lymph Node Biopsy
Ultrasonography, Interventional
Adult
Aged
Axilla
Biopsy, Fine-Needle
Breast Neoplasms
Carcinoma, Ductal, Breast
Carcinoma, Lobular
Feasibility Studies
Female
Humans
Lymph Nodes
Lymphatic Metastasis
Middle Aged
Neoplasm Staging
Point-of-Care Systems
Prenatal Care
Sensitivity and Specificity
Sentinel Lymph Node Biopsy
Ultrasonography, Interventional
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Abstract
Axillary ultrasonography (AUS) and fine-needle aspiration cytology (FNAC) can establish axillary lymph node status before surgery, although this technique is hampered by poor adequacy rates. To achieve consistently high rates of FNAC adequacy, rapid on-site evaluation (ROSE) of FNAC samples was introduced.
Language
en
ISSN
1365-2168
eISSN
ISBN
DOI
10.1002/bjs.8738
PMID
22473359